Effect of interferon-α induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection: A randomized multicentre study

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 3, 2002, Pages 344-349

  Bjøro, Kristian ^a   Bell, H ^a   Myrvang, B ^a   Skaug, K ^a   Raknerud, N ^a   Sandvei, P ^a   Storseth S ^a   Ritland, S ^a   Lund Tonnesen S ^a   Bucher, A ^a   Hellum, K B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Hepatitis C; Interferon

Indexed keywords

ALPHA INTERFERON; ROCERON; VIRUS RNA;

ADULT; ARTICLE; ASTHENIA; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FEVER; FOLLOW UP; GENOTYPE; HEADACHE; HEPATITIS C; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MYALGIA; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; THYROID DISEASE; TREATMENT OUTCOME; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; PROBABILITY; REMISSION INDUCTION; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0011960499     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202317284264     Document Type: Article

References (24)

1. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial
2. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. Meta-analysis
3. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
4. Two dose regimens of recombinant interferon-alpha-2b in chronic hepatitis C virus infection. Biochemistry, hepatitis C virus RNA, and liver histology as response indices
5. Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C
6. Hepatitis C virus genotypes in the United States: Epidemiology, pathogenicity, and response to interferon therapy
7. Pathogenesis, natural history, treatment, and prevention of hepatitis C
8. Interferon treatment of cirrhotic patients with chronic hepatitis C
9. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks
10. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C effects of dose and duration
11. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa
12. Comparison of high initial and fixed-dose regimens of interferon-alpha2a in chronic hepatitis C: A randomized controlled trial
13. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy
14. Interferon alfacon-1 induction therapy: A multicenter trial in subjects with chronic hepatitis C virus infection
15. Failure of interferon induction dosing to alter sustained response rates in patients with chronic hepatitis C
16. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis interventional therapy
17. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
18. The effect of combined interferon-α induction therapy and ribavirin on chronic hepatitis C virus infection - A randomised multicenter study
19. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin
20. Improvement of HCV genom detection with 'short' PCR products
21. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
22. Early hepatitis C virus-RNA responses predict interferon treatment outcomes in chronic hepatitis C
23. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C effects of dose and duration
24. Is an 'A la carte' combination interferon alfa-2b plus ribavirin regimen posible for the first line treatment in patients with chronic hepatitis C?